Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
Lupin has gotten endorsement for its Trientine Hydrochloride Capsules USP, 250 mg, from the United States Food and Drug Administration (USFDA), to showcase a conventional likeness Syprine Capsules, 250 mg, of Bausch Health US, LLC.
The item would be fabricated at Lupin’s Nagpur (Unit 1) office, India.
Trientine Hydrochloride Capsules USP, 250 mg, are demonstrated in the treatment of patients with Wilson’s ailment who are narrow minded of penicillamine.
Trientine Hydrochloride Capsules USP (RLD: Syprine) had a yearly deals of around USD 86 million in the U. S.